Intra-host analysis of hepaciviral glycoprotein evolution reveals signatures associated with viral persistence and clearance

Abstract. Even 30 years after the discovery of the hepatitis C virus (HCV) in humans there is still no vaccine available. Reasons for this include the high muta

Saved in:
Bibliographic Details
Main Authors: Gömer, André Philipp (Author) , Brown, Richard J. P. (Author) , Pfänder, Stephanie (Author) , Deterding, Katja (Author) , Reuter, Gábor (Author) , Orton, Richard (Author) , Seitz, Stefan (Author) , Bock, C.-Thomas (Author) , Cavalleri, Jessika M. V. (Author) , Pietschmann, Thomas (Author) , Wedemeyer, Heiner (Author) , Steinmann, Eike (Author) , Todt, Daniel (Author)
Format: Article (Journal)
Language:English
Published: 02 February 2022
In: Virus evolution
Year: 2022, Volume: 8, Issue: 1, Pages: 1-14
ISSN:2057-1577
DOI:10.1093/ve/veac007
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/ve/veac007
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/ve/article/8/1/veac007/6520266
Get full text
Author Notes:André Gömer, Richard J.P. Brown, Stephanie Pfaender, Katja Deterding, Gábor Reuter, Richard Orton, Stefan Seitz, C.-Thomas Bock, Jessika M.V. Cavalleri, Thomas Pietschmann, Heiner Wedemeyer, Eike Steinmann, and Daniel Todt
Description
Summary:Abstract. Even 30 years after the discovery of the hepatitis C virus (HCV) in humans there is still no vaccine available. Reasons for this include the high muta
Item Description:Gesehen am 01.06.2022
Physical Description:Online Resource
ISSN:2057-1577
DOI:10.1093/ve/veac007